Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Factor Medical is an Australian regenerative medicine company that developed and commercializes Factor4, an advanced autologous cytokine-rich serum (ACS). The technology utilizes a proprietary incubation process where the patient's own blood is exposed to specialized technological tubing to stimulate the production of anti-inflammatory cytokines, particularly Interleukin-1 receptor antagonist (IL-1Ra), and various growth factors. The resulting serum, which contains significantly higher concentrations of these proteins than standard platelet-rich plasma (PRP), is used clinically for treating musculoskeletal conditions like osteoarthritis and joint pain, as well as in aesthetic medicine for skin rejuvenation and hair loss. Factor Medical focuses on providing natural, blood-derived alternatives to traditional pharmacological treatments for inflammation and tissue repair.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Factor Medical.